RxDoctor Payments Data

Alfred Lavi, DO

Family Medicine · Los Angeles, CANPI 1184739039

Payments from drug & device makers

$1,113in general payments, 2019–2025

Across 54 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$177
  • Cranial Technologies, Inc$150
  • Amgen$137
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$88
  • Novo Nordisk$87
  • AstraZeneca$86
  • plus $389 from 11 others

What the payments were for

  • Food & beverage$1,113100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,113 in reported general payments places this provider in the 75th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$34,997
Medicare patients
105
Services billed
330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$24,979
FarxigaDapagliflozin Propanediol16$21,254
EliquisApixaban29$19,157
LinzessLinaclotide13$6,916
Xigduo XrDapaglifloz Propaned/Metformin12$6,754
Dexlansoprazole DrDexlansoprazole13$4,585
Atorvastatin Calcium172$1,487
Metformin Hcl160$977
Metoprolol Succinate43$721
Amitriptyline Hcl25$719
Albuterol Sulfate HfaAlbuterol Sulfate28$666
Losartan Potassium51$566
Diclofenac Sodium12$377
Omeprazole58$348
Lisinopril79$342

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$87$24,97922 claims
AstraZenecaFarxiga$86$21,25416 claims
PfizerEliquis$54$19,15729 claims
AbbVieLinzess$15$6,91613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,533 family medicine providers in California.

Other family medicine in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →